Filter Results:
(141)
Show Results For
- All HBS Web
(141)
- News (55)
- Research (66)
- Multimedia (3)
- Faculty Publications (22)
Show Results For
- All HBS Web
(141)
- News (55)
- Research (66)
- Multimedia (3)
- Faculty Publications (22)
- 12 Jul 2021
- News
Alumni Confront the COVID-19 Crisis
treat non-hospitalized patients with COVID-19. Dapansutrile aims to selectively target the immune system’s intense inflammatory response to the SARS-CoV-2 viral infection that can lead to a “cytokine storm.” As such, it is well positioned... View Details
- 13 Feb 2019
- News
We’re All Going to Get Hacked
detection, right? Ba-doop, doop! The alarm goes off, the white blood cells get it, but the red blood cells do the repair. So, the human immune system is a perfect example. It doesn’t know where the threat’s going to come from; it doesn’t... View Details
- Web
2023 Symposium - Race, Gender & Equity
(2001), and Immunity to Change (2009) have been published in over a dozen languages. Her latest book, An Everyone Culture, published by the Harvard Business Press, will be out this spring, 2016. Initiatives focus on societal challenges... View Details
- 27 Mar 2019
- News
Life Is a Startup
assaulting our immune system by getting vaccinated. Well, that’s forging a stronger body for having that brief setback from the vaccination. If you think about our muscles when we’re exercising, what are doing to our muscles? We’re... View Details
- 06 Dec 2021
- News
What's the Word?
allowing users to retain relative anonymity. Back to top Bi·o·rev·o·loo·shun (noun) As the months of the pandemic ticked by, many of us were transfixed by progress updates on vaccine development. Moderna’s mRNA technology, we learned, uses molecules to carry the... View Details
- 15 Dec 2015
- News
The Year in Ideas 2015
the body’s immune system can clear them.” The molecule also has potential applications beyond Alzheimer’s, including Parkinson’s, Huntington’s, and several rare diseases—all characterized by damaging brain buildups. “It’s a golden... View Details
- 02 Sep 2014
- First Look
First Look: September 2
vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pasteur,... View Details
Keywords: Sean Silverthorne
- 08 Oct 2013
- First Look
First Look: October 8
has sharply declined over the past 30 years, from 60% or 70% to only about 20%. What accounts for this trend? Disruption is coming for management consulting, the authors say, as it has recently come for law. For many years the professional services were View Details
Keywords: Sean Silverthorne